Synthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-cell antigen CD20.
about
Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsPolymer-drug conjugates: origins, progress to date and future directionsA hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibodyMultivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.HPMA copolymers: origins, early developments, present, and future.Macromolecular therapeuticsIn situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulationPeptides and peptidomimetics as immunomodulators.Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cellsEngineering polymeric aptamers for selective cytotoxicity.Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to RituximabCoiled-coil based drug-free macromolecular therapeutics: in vivo efficacy.Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesEncapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles.Biological rationale for the design of polymeric anti-cancer nanomedicines.POLYMERIC BIOMATERIALS AND NANOMEDICINES.Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosisCell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action and in vivo activity.Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface.Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.Design of smart HPMA copolymer-based nanomedicines.Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.
P2860
Q26823789-4D1F3D7B-EA74-4440-B499-262B06356513Q27002505-FFDA4B3B-A863-4289-88C2-DC6F2126D4EEQ30420026-4BEED134-8200-4186-9A13-685CA42D8FFEQ33625151-0928A90A-2900-407E-8D4F-72B519B7223CQ33719148-AEDADCEB-5E94-4094-9DAA-FC8ED50AE3CDQ34079574-94665A88-B99B-4A6A-A50B-037DC49C1886Q34151598-637B71D1-A764-47BC-9D49-CB783DE1B3D8Q34359984-9ECC1572-F3C9-4C46-8A7C-48F6FA54DDC5Q34394867-F5F8AA81-3973-4EAC-839D-5C498DD5341CQ34855819-39B071F1-F93F-445B-A2CA-7F43EFF98D0FQ35308685-10EABB74-7552-47B7-AD1A-2DC486BEC2C9Q35611416-F46280FC-58AC-4A1E-B46D-B5C2E2E6458AQ35633346-14F31A2C-D5F4-466D-9ED0-3022F1C3BCF3Q35678195-B57E154D-E579-4E5B-9E63-A4122C39DA3FQ35861726-8142F28F-D758-4A0F-B1C8-86A4D4A4A7AFQ35993977-EE928B78-E436-44AA-91E8-7F3F68518853Q36160333-A9994C57-4D8E-4B94-8BBD-FC7AA0DB973AQ36376467-DE393EBB-C09C-472B-B1CF-5998CA020421Q36611125-8A7ADBEB-EDF5-4E55-88FB-5652B11A7A3AQ37537969-E6B2190C-35D9-425F-B7D1-D5DE3BCB1C5EQ38636559-2916D335-E917-4093-9A06-16143713F332Q39455947-8F6ECB66-7945-474D-A1BB-65CACFA2FE6EQ39747863-E8B6D726-B540-428A-8AE8-A5C1E2FDB445Q41910884-80E9BFD6-33AD-49A6-9744-9BBF6BD54CE1Q42553783-6D21C069-6A0C-4324-A7BA-8B1B04B6BC97Q53609318-6EEF56F3-64EA-4C50-8B93-4447F6EFA9B3
P2860
Synthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-cell antigen CD20.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@ast
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@en
type
label
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@ast
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@en
prefLabel
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@ast
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@en
P2093
P2860
P356
P1476
Synthesis and evaluation of mu ...... ed to the B-cell antigen CD20.
@en
P2093
Jindrich Kopecek
Pavla Kopecková
Russell N Johnson
P2860
P304
P356
10.1021/BC800351M
P577
2009-01-01T00:00:00Z